Dagmar Stoiber
Krems An Der Donau, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Revealing an unconventional JAK1/2-STAT3 branch in macrophage IFN-γ signaling.
Journal: Cell reports
Published: August 13, 2025
Loss of STAT3 in acute myeloid leukemia favors tissue infiltration linked to CXCR4 signaling.
Journal: Blood neoplasia
Published: December 16, 2024
Atovaquone and selinexor as a novel combination treatment option in acute myeloid leukemia.
Journal: Cancer letters
Published: October 07, 2024
Preclinical in vitro and in vivo evidence for targeting CD74 as an effective treatment strategy for cutaneous T-cell lymphomas.
Journal: The British journal of dermatology
Published: August 08, 2024
How enoxaparin underdosing and sex contribute to achieving therapeutic anti-Xa levels.
Journal: Frontiers in pharmacology
Published: April 18, 2024
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity.
Journal: Blood cancer journal
Published: April 13, 2024
STAT3 in acute myeloid leukemia facilitates natural killer cell-mediated surveillance.
Journal: Frontiers in immunology
Published: January 21, 2024
A novel function of STAT3β in suppressing interferon response improves outcome in acute myeloid leukemia.
Journal: Cell death & disease
Published: December 14, 2023
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
Journal: Molecular cancer
Published: March 23, 2023
Editorial: Innate lymphocytes in tumor surveillance.
Journal: Frontiers in immunology
Published: November 08, 2022
The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 19, 2022
Last Updated: 09/26/2026